233 related articles for article (PubMed ID: 831074)
1. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.
Toyka KV; Drachman DB; Griffin DE; Pestronk A; Winkelstein JA; Fishbeck KH; Kao I
N Engl J Med; 1977 Jan; 296(3):125-31. PubMed ID: 831074
[TBL] [Abstract][Full Text] [Related]
2. [A transferable "myasthenogenic" factor in the serum of patients with myasthenia gravis (author's transl)].
Toyka KV; Drachman DB; Pestronk A; Fischbeck H; Kao I
J Neurol; 1976 Jun; 212(3):271-80. PubMed ID: 58978
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.
Tüzün E; Saini SS; Ghosh S; Rowin J; Meriggioli MN; Christadoss P
Neuromuscul Disord; 2006 Feb; 16(2):137-43. PubMed ID: 16427283
[TBL] [Abstract][Full Text] [Related]
4. Passive transfer of seronegative myasthenia gravis to mice.
Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
[TBL] [Abstract][Full Text] [Related]
5. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of myasthenia gravis as a disorder of acetylcholine receptors.
Drachman DB; Pestronk A; Stanley EF
Adv Cytopharmacol; 1979; 3():237-44. PubMed ID: 382787
[No Abstract] [Full Text] [Related]
7. Myasthenia gravis: passive transfer from man to mouse.
Toyka KV; Brachman DB; Pestronk A; Kao I
Science; 1975 Oct; 190(4212):397-9. PubMed ID: 1179220
[TBL] [Abstract][Full Text] [Related]
8. Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab')2 hybrid molecules.
Sterz R; Hohlfeld R; Rajki K; Kaul M; Heininger K; Peper K; Toyka KV
Muscle Nerve; 1986 May; 9(4):306-12. PubMed ID: 2423869
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6.
Biesecker G; Gomez CM
J Immunol; 1989 Apr; 142(8):2654-9. PubMed ID: 2703710
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
Burres SA; Crayton JW; Gomez CM; Richman DP
Ann Neurol; 1981 Jun; 9(6):563-8. PubMed ID: 6167199
[TBL] [Abstract][Full Text] [Related]
11. Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes.
Richman DP; Patrick J; Arnason BG
N Engl J Med; 1976 Mar; 294(13):694-8. PubMed ID: 129705
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
[TBL] [Abstract][Full Text] [Related]
13. Myasthenia gravis (first of two parts).
Drachman DB
N Engl J Med; 1978 Jan; 298(3):136-42. PubMed ID: 201840
[No Abstract] [Full Text] [Related]
14. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma.
Kim YI
Muscle Nerve; 1985 Feb; 8(2):162-72. PubMed ID: 2997605
[TBL] [Abstract][Full Text] [Related]
15. Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis.
Mittag T; Kornfeld P; Tormay A; Woo C
N Engl J Med; 1976 Mar; 294(13):691-4. PubMed ID: 1250280
[TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model.
Toyka KV; Birnberger KL; Anzil AP; Schlegel C; Besinger U; Struppler A
J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):746-53. PubMed ID: 210263
[TBL] [Abstract][Full Text] [Related]
17. Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis.
Abramsky O; Aharonov A; Webb C; Fuchs S
Clin Exp Immunol; 1975 Jan; 19(1):11-6. PubMed ID: 1239345
[TBL] [Abstract][Full Text] [Related]
18. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
Corey AL; Richman DP; Agius MA; Wollmann RL
J Immunol; 1987 May; 138(10):3269-75. PubMed ID: 3494763
[TBL] [Abstract][Full Text] [Related]
19. The immunopathology of myasthenia gravis.
Lennon VA
Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 1.
Simpson JA
Muscle Nerve; 1978; 1(1):45-56. PubMed ID: 377070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
